-
Alza Corporation, et al v. Mylan Laboratories, et al DC
- 2:02-cv-00213
- D. Vt.
- Judge: William K. Sessions III
- Filed: 09/03/2002
- Closed: 03/26/2004
- Latest Docket Entry: 03/26/2004
- PACER
- Docket updated daily
2
Plaintiffs
3
Defendants
1
Accused
Product
1
Patent-in-Suit
571
Days in
Litigation
-
Alza Corporation, et al v. Mylan Laboratories, et al DC
- 2:02-cv-00213
- D. Vt.
- Judge: William K. Sessions III
- Filed: 09/03/2002
- Closed: 03/26/2004
- Latest Docket Entry: 03/26/2004
- PACER
- Docket updated daily
Cause of Action
Willful Patent Infringement
Market Sector
Biotech and Pharma
Court
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
Claim # | Claim Text | Outcome |
---|---|---|
27 |
The medical device of claim 25 wherein said material is fentanyl base.
|
Enforceable and Valid (102 and 103)
Entry 14 |
-
Infringement
Mylan Laboratories Incorporated
- 1 Detail
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
Generic duragesic fentanyl transdermal patches | US 4,588,580 A |
27
|
Infringement
Entry 14
|
Mylan Pharmaceuticals Incorporated
- 1 Detail
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
Generic duragesic fentanyl transdermal patches | US 4,588,580 A |
27
|
Infringement
Entry 14
|
Mylan Technologies Incorporated
- 1 Detail
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
Generic duragesic fentanyl transdermal patches | US 4,588,580 A |
27
|
Infringement
Entry 14
|